Health Blueprint

Back to Longevity News

News summary

Argá Medtech Completes Enrollment of Paroxysmal AF Cohort in the COHERENT-AF Pivotal IDE Study

Source: PR Newswire • Published: 11 Nov 2026, 19:52

Summarized by Masters of Longevity from PR Newswire.

The COHERENT-AF trial enrolled 150 paroxysmal AF patients for CSE platform evaluation.

Argá Medtech Completes Enrollment of Paroxysmal AF Cohort in the COHERENT-AF Pivotal IDE Study
Key Takeaways
  • The trial enrolled 150 paroxysmal AF patients across 27 sites.
  • The CSE system delivers sine-wave pulsed field ablation with one catheter.
  • Twelve-month safety and effectiveness data are being separately evaluated.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.MoL PickLongevity is leaving the clinicStephen Watson argues that hotels, gyms and residential communities can build longevity memberships around the relationships they already have.MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?